Sarah

Sarah is 55. She is married with two adult children, who are 20 and 22. Before she retired, she worked as a pediatric intensive care nurse. Ethnicity: white British.

Sarah was diagnosed with MND in 2019. Although her father had the disease previously, she only recently discovered that she has an inherited form through genetic testing. Sarah is hopeful that this information will help future generations of the family.

Sarah developed MND in 2019, which started with a weakness in her arm. She initially thought this could be a shoulder injury, as she did a lot of lifting as a nurse. However, when this didn’t get better, she went to her GP who conducted nerve tests. Her GP was reluctant to give Sarah the results and referred her to a neurologist. After issues with receiving an NHS appointment, she booked a private appointment. Sarah went to her GP surgery to collect her nerve test results to take with her, and saw on the paperwork that her GP suspected she had an Anterior Horn Disease, of which MND is one. Around this time, she also started to have fasciculations (involuntary muscle contractions), something her father, who had had the disease when Sarah was in her 20s, had also spoken about. The neurologist gave her a diagnosis of MND, which unfortunately confirmed what she already expected.

Initially, it didn’t occur to Sarah that her MND was inherited; it could have just been unluck. However, after she was diagnosed, the family started to read more about MND and realised this was a possibility. Sarah was offered genetic testing when she went for screening to take part in a research study. She had the genetic test and recently received a phone call from the consultant confirming that she has the C9orf72 genetic variant. Sarah describes feeling guilty and sad that she hadn’t stopped the disease in her family. However, she feels that in a way it is positive to have this information, which may help her children and nephews make future decisions around things like starting their own families. After being told by the consultant about pre-symptomatic genetic testing, Sarah’s daughter and sister are considering this option.

Since developing symptoms, Sarah has made changes to her life. She can no longer do work in the house and garden and needs help from her husband with personal care. She has retired from her job, which she had planned to continue for some years, and is preparing to make adaptations to her house. Going out is becoming more difficult, and Sarah has had to give up activities she previously enjoyed, like walking holidays.

Sarah has had physiotherapy and hydrotherapy to help with her symptoms, and has seen an occupational therapist, who has arranged supports and aids. She also uses alternative therapies, such as taking turmeric for aches and pains. Sarah has started to plan for her future care and has signed a Do Not Resuscitate order (DNR) to ensure her wishes are respected. From her experiences in intensive care nursing, she is aware of some of the challenges she may face. She does not want certain interventions like ventilation, if the life she will be living is very different to the one she had before.

Sarah is disappointed that treatments for MND have not advanced significantly since her father was affected, and is keen to participate in research and trials around the disease. She feels that a treatment will not come soon enough for her, but her attitude is if I have this disease, I might as well be usefu. Joining trials has been difficult due to COVID-19, which has caused delays and disruptions to such studies, and whilst Sarah would like to have this opportunity, she worries about the practicalities of travelling as her disease progresses. Sarah encourages healthcare professionals to keep in mind that finding out about an inherited form of MND can be upsetting for people. However, she is hopeful for research progress in the future.

Sarah has written a Do Not Resuscitate order. Her decision was informed by caring for her father, who died of MND, as well as her experiences as a children’s nurse.

Age at interview 55

Gender Female

Age at diagnosis 54

Sarah is disappointed that in the 32 years since her father has died, there has been little progress in treatments for MND. She would like to take part in research to be “useful”.

Age at interview 55

Gender Female

Age at diagnosis 54

After being told she carried the C9orf72 gene variant, Sarah felt “guilty”. She said it was disappointing, “but at least there’s proactive things you can do about it”.

Age at interview 55

Gender Female

Age at diagnosis 54

Sarah retired earlier than she would have liked to but felt lucky to be able to take her pension at 55.

Age at interview 55

Gender Female

Age at diagnosis 54

Sarah didn’t initially consider that she could have an inherited form of MND; it could have been “unlucky” that both she and her father had been affected.

Age at interview 55

Gender Female

Age at diagnosis 54